RESEARCH-USE BIOSIMILAR ANTIBODY
Dostarlimab
Monoclonal antibody · IgG4
Dostarlimab (TSR-042) is a humanized anti-PD-1 monoclonal antibody. Dostarlimab binds with high affinity to human PD-1 and competitively inhibits its interaction with its ligands, PD-L1 and PD-L2, with IC50s of 1.8 and 1.5 nM, respectively.
TARGETPDCD1
YMonoclonal antibody
CATALOGSC-BS-618
CATALOG NUMBERSC-BS-618
MOLECULAR WEIGHTApprox. 144.18 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Dostarlimab (TSR-042) is a humanized anti-PD-1 monoclonal antibody. Dostarlimab binds with high affinity to human PD-1 and competitively inhibits its interaction with its ligands, PD-L1 and PD-L2, with IC50s of 1.8 and 1.5 nM, respectively.
Dostarlimab is a recombinant research-use antibody directed against PDCD1.